Literature DB >> 28039560

Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill".

Avivit Cahn1,2, Eytan Roitman3, Genya Aharon-Hananel4, Itamar Raz5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28039560     DOI： 10.1007/s12020-016-1217-x

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  19 in total

1.  Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control.

Authors:  Giuseppe Lepore; Anna Corsi; Alessandro R Dodesini; Italo Nosari; Roberto Trevisan
Journal:  Diabetes Care       Date:  2010-06       Impact factor: 19.112

Review 2.  Review of clinical trials: update on oral insulin spray formulation.

Authors:  Paolo Pozzilli; Philip Raskin; Christopher G Parkin
Journal:  Diabetes Obes Metab       Date:  2009-11-02       Impact factor: 6.577

3.  Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study.

Authors:  Maria Ida Maiorino; Ofelia Casciano; Elisabetta Della Volpe; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2015-07-17       Impact factor: 3.633

4.  New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?

Authors:  Eberhard Standl; David R Owen
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

5.  Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.

Authors:  Anne L Peters; Andrew J Ahmann; Tadej Battelino; Alison Evert; Irl B Hirsch; M Hassan Murad; William E Winter; Howard Wolpert
Journal:  J Clin Endocrinol Metab       Date:  2016-09-02       Impact factor: 5.958

Review 6.  Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis.

Authors:  Khalid Benkhadra; Fares Alahdab; Shrikant U Tamhane; Rozalina G McCoy; Larry J Prokop; Mohammad Hassan Murad
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

7.  Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.

Authors:  P G Jacobs; J El Youssef; R Reddy; N Resalat; D Branigan; J Condon; N Preiser; K Ramsey; M Jones; C Edwards; K Kuehl; J Leitschuh; U Rajhbeharrysingh; J R Castle
Journal:  Diabetes Obes Metab       Date:  2016-08-15       Impact factor: 6.577

8.  Low-Blood Glucose Avoidance Training Improves Glycemic Variability in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: HypoCOMPaSS Trial.

Authors:  Horng Kai Tan; Stuart A Little; Lalantha Leelarathna; Emma Walkinshaw; Alexandra Lubina-Solomon; Joanne Hosking; Jane Speight; David Kerr; Simon R Heller; Mark L Evans; James A M Shaw; Daniel Flanagan
Journal:  Diabetes Care       Date:  2016-03-07       Impact factor: 19.112

9.  Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).

Authors:  Stuart A Little; Lalantha Leelarathna; Emma Walkinshaw; Horng Kai Tan; Olivia Chapple; Alexandra Lubina-Solomon; Thomas J Chadwick; Shalleen Barendse; Deborah D Stocken; Catherine Brennand; Sally M Marshall; Ruth Wood; Jane Speight; David Kerr; Daniel Flanagan; Simon R Heller; Mark L Evans; James A M Shaw
Journal:  Diabetes Care       Date:  2014-05-22       Impact factor: 19.112

10.  The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.

Authors:  Ignacio Conget; Javier Castaneda; Goran Petrovski; Bruno Guerci; Anne-Sophie Racault; Yves Reznik; Ohad Cohen; Sarah Runzis; Simona de Portu; Ronnie Aronson
Journal:  Diabetes Technol Ther       Date:  2015-08-04       Impact factor: 6.118
View more
  1 in total

1.  Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.

Authors:  Zahra Razavi; Saba Maher; Javad Fredmal
Journal:  Endocrine       Date:  2018-05-24       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.